ILIAS Biologics Inc. demonstrated the therapeutic effect of anti-inflammatory exosomes for ischemia-reperfusion-induced acute kidney injury; ILIAS published its third POC study in Kidney International suggesting a potential treatment for inflammatory dise

Press/Media: Press / Media

Period2021 Jun 28

Media coverage

1

Media coverage

  • TitleILIAS Biologics Inc. demonstrated the therapeutic effect of anti-inflammatory exosomes for ischemia-reperfusion-induced acute kidney injury; ILIAS published its third POC study in Kidney International suggesting a potential treatment for inflammatory dise
    Media name/outletPR Newswire
    Country/TerritoryUnited States
    Date21/6/28
    PersonsTaeHyun Yoo
View all 1
View less